Bracco, ImaRx sign licensing pact

Milan, Italy-based contrast agent developer Bracco and biopharmaceutical firm ImaRx Therapeutics of Tucson, AZ, have signed a cross-license agreement for certain patents and patent applications of each other's products.

ImaRx granted to Bracco worldwide, royalty free, nonexclusive rights for certain microbubble compositions solely for use in targeted diagnostic imaging applications.

In return, Bracco gave ImaRx the same rights, patents, and patent applications related to certain microbubble compositions solely for use in therapeutic applications.

By AuntMinnie.com staff writers
July 4, 2007

Related Reading

ImaRx files S-1 for IPO, May 5, 2007

Unger steps down at ImaRx, October 24, 2006

ImaRx buys Abbokinase, May 9, 2006

VisualSonics, Bracco partner, June 8, 2006

Bracco opens perfusion PET company, June 1, 2006

Copyright © 2007 AuntMinnie.com

Page 1 of 1261
Next Page